Moody National Bank Trust Division Grows Stock Position in CVS Health Co. (NYSE:CVS)

Moody National Bank Trust Division grew its stake in shares of CVS Health Co. (NYSE:CVS) by 3.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 24,185 shares of the pharmacy operator’s stock after acquiring an additional 885 shares during the quarter. Moody National Bank Trust Division’s holdings in CVS Health were worth $1,086,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the stock. MidAtlantic Capital Management Inc. acquired a new stake in shares of CVS Health during the third quarter worth $25,000. Ridgewood Investments LLC raised its stake in CVS Health by 255.7% in the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 450 shares during the last quarter. Livelsberger Financial Advisory purchased a new stake in CVS Health during the 3rd quarter valued at about $31,000. Legacy Investment Solutions LLC acquired a new position in shares of CVS Health in the third quarter valued at about $31,000. Finally, Reston Wealth Management LLC purchased a new position in shares of CVS Health in the third quarter worth about $32,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Up 7.4 %

CVS stock opened at $51.54 on Tuesday. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $80.75. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The firm has a 50-day simple moving average of $51.76 and a 200-day simple moving average of $56.49. The stock has a market capitalization of $64.86 billion, a P/E ratio of 13.08, a P/E/G ratio of 0.85 and a beta of 0.59.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.08 by $0.01. The company had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. CVS Health’s quarterly revenue was up 6.3% on a year-over-year basis. During the same period in the previous year, the business earned $2.21 EPS. Equities analysts forecast that CVS Health Co. will post 5.32 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be paid a dividend of $0.665 per share. The ex-dividend date is Thursday, January 23rd. This represents a $2.66 annualized dividend and a yield of 5.16%. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

Wall Street Analysts Forecast Growth

CVS has been the topic of several research reports. UBS Group increased their price target on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a report on Thursday, November 7th. Wells Fargo & Company raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $60.00 to $66.00 in a report on Monday, November 18th. TD Cowen upped their price target on shares of CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a report on Monday, November 25th. StockNews.com cut CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. Finally, Evercore ISI raised their target price on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $68.71.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.